Middle East and Africa Compression Therapy Market is expected to reach US$ 102.9 Million by 2034

According to The Insight Partners' research, the Middle East and Africa Compression Therapy Market was valued at US$ 80.9 Million in 2025 and is expected to reach US$ 102.9 Million by 2034, registering a CAGR of 2.8% from 2026 to 2034.

Clinical endorsements & expanded practice guidelines and decentralized & home-based care adoption are among the critical factors attributed to driving the Middle East & Africa compression therapy market growth.

Government-linked health bodies and systematic reviews provide authoritative support for the therapeutic role of compression products. For instance, evidence synthesized in clinical guidelines recommends using graduated compression stockings (GCS) as a prophylactic intervention to reduce the incidence of deep vein thrombosis (DVT) in at-risk surgical patients, underscoring compression therapy’s role in standard thromboprophylaxis protocols. 

Official health information sources, such as MedlinePlus (run by the U.S. National Library of Medicine), also list compression stockings among recommended strategies to prevent DVT, especially during prolonged immobility, reinforcing their preventive health value. These clinical endorsements from respected institutions support broader integration of compression therapy into guideline-based practices across hospitals, rehabilitation centers, and outpatient care. This not only legitimizes the therapy to clinicians and payers but also encourages product innovation tailored to specific clinical indications, from post-surgical recovery and chronic venous insufficiency to settings such as maternal care and elderly preventative programs, expanding the total addressable use cases.

On the contrary, complex regulatory approval and product compliance requirements hamper growth in the Middle East & Africa compression therapy market.

Middle East and Africa Compression Therapy Market Segmentation Analysis:

• By Product, the Middle East and Africa Compression Therapy Market is segmented into Compression Bandages, Compression Wraps, Compression Stockings, Compression Sleeves, Compression Tape, Compression Braces, Compression Pumps, and Others. The Compression Bandages segment is projected to expand at a CAGR of 3.3% during 2026 - 2034.
• By Technology, the Middle East and Africa Compression Therapy Market is segmented into Static Compression Therapy and Dynamic Compression Therapy. The Static Compression Therapy segment is projected to expand at a CAGR of 2.7% during 2026 - 2034.
• By Application, the Middle East and Africa Compression Therapy Market is segmented into Lymphedema, Leg Ulcer, Deep Vein Thrombosis, Varicose Veins, Lipedema, and Others. The Varicose Veins segment is projected to expand at a CAGR of 2.8% during 2026 - 2034.
• By End User, the Middle East and Africa Compression Therapy Market is segmented into Hospitals and Clinics, Nursing Care Centers, Home Care Settings, and Other End Users. The Hospitals and Clinics segment is projected to expand at a CAGR of 3.1% during 2026 - 2034.

By country, the Middle East and Africa Compression Therapy Market is categorized into Saudi Arabia, South Africa, the United Arab Emirates, and the Rest of Middle East and Africa. South Africa is projected to expand at a CAGR of 2.9% during 2026 - 2034.

Key players operating in the Compression Therapy Market are Arjo AB, Essity AB, Lohmann & Rauscher GmbH & Co KG, Paul Hartmann AG, Convatec Inc, Enovis Corp, Solventum Corporation, Juzo, SIGVARIS GROUP, and medi Canada Inc, among others.

• In May 2023; Wound care expert HARTMANN and the compression wrap specialist Sigvaris have announced a strategic partnership in the field of compression therapy. Wound care expertise will be combined with adjustable wrap know-how to commercialize a highly effective range of compression therapy products. The partnership increases the visibility of both corporations in new segments. In addition, it facilitates greater access to high-quality and adjustable compression wrap systems that ensure easy at-home treatment.